Company Filing History:
Years Active: 2004-2014
Title: John Tinsman Patton, Jr: Innovator in Selectin Modulation
Introduction
John Tinsman Patton, Jr. is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that modulate selectin binding processes. With a total of 12 patents to his name, Patton's work has implications for various therapeutic applications.
Latest Patents
Patton's latest patents focus on heterobifunctional pan-selectin inhibitors. These patents describe compounds and methods for modulating in vitro and in vivo processes mediated by selectin binding. Specifically, the selectin modulators can inhibit or enhance selectin-mediated functions. They comprise particular glycomimetics, which can be linked to compounds known as Benzyl Amino Sulfonic Acids (BASAs) or Benzyl Amino Carboxylic Acids (BACAs).
Career Highlights
Throughout his career, Patton has worked with prominent companies in the pharmaceutical industry, including Glycomimetics, Inc. and Novartis AG. His expertise in selectin modulation has positioned him as a key figure in the development of innovative therapeutic strategies.
Collaborations
Patton has collaborated with esteemed colleagues such as John L. Magnani and Arun K. Sarkar. These partnerships have furthered research and development in the field of selectin inhibitors.
Conclusion
John Tinsman Patton, Jr. is a distinguished inventor whose work in selectin modulation has the potential to impact therapeutic approaches significantly. His contributions to the field are marked by a series of innovative patents and collaborations with leading professionals.